Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2011; 17(30): 3526-3530
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3526
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3526
Table 1 Baseline characteristics of patients
Variables | |
No. of patients | 77 |
Age (yr, mean ± SD) | 49.3 ± 11.7 |
Female: Male (n, % male) | 18: 59 (77%) |
HBeAg positive (n, % positive) | 21: 56 (73%) |
ALT (U/L, median, range) | 119 (25–926) |
AST (U/L, median, range) | 77 (30–483) |
Albumin (g/dL, median, range) | 4.0 (2.6–4.6) |
Total bilirubin (mg/dL, median, range) | 1.0 (0.3–4.0) |
Prothrombin time (INR, median, range) | 1.1 (0.9–1.7) |
Baseline creatinine level (mg/dL, mean ± SD) | 0.90 ± 0.13 |
Creatinine level at weeks 96 (mg/dL, mean ± SD) | 0.94 ± 0.16 |
LAM resistance mutation profile (n, %) | |
rtM204I ± rtL180M | 48 (62%) |
rtM204V ± rtL180M | 29 (38%) |
- Citation: Sinn DH, Lee HI, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Virological response to adefovir monotherapy and the risk of adefovir resistance. World J Gastroenterol 2011; 17(30): 3526-3530
- URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3526.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3526